loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of FDA Orange Book Patents covering 8158156

    Client Virtual Booth
    Menu

    Actavis Inc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ALPHARMA PHARMS (6)

    filter

    01 8158156 (6)

    filter

    01 Blank (6)

    filter

    01 Blank (6)

    filter

    01 2027-06-19 (6)

    refreshReset Filter
    refreshReset Filter
    price-trendAsk Us

    ALPHARMA PHARMS

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    8158156
    2027-06-19
    U-1510
    22321
    MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG TERM OPIOD TREATEMENT BY ORALLY ADMINISTERING AN INTACT COMPOSITION AS CLAIM
    5
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ALPHARMA PHARMS

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    8158156
    2027-06-19
    U-1510
    22321
    MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG TERM OPIOD TREATEMENT BY ORALLY ADMINISTERING AN INTACT COMPOSITION AS CLAIM
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ALPHARMA PHARMS

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    8158156
    2027-06-19
    U-1510
    22321
    MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG TERM OPIOD TREATEMENT BY ORALLY ADMINISTERING AN INTACT COMPOSITION AS CLAIM
    4
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ALPHARMA PHARMS

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    8158156
    2027-06-19
    U-1510
    22321
    MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG TERM OPIOD TREATEMENT BY ORALLY ADMINISTERING AN INTACT COMPOSITION AS CLAIM
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ALPHARMA PHARMS

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    8158156
    2027-06-19
    U-1510
    22321
    MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG TERM OPIOD TREATEMENT BY ORALLY ADMINISTERING AN INTACT COMPOSITION AS CLAIM
    6
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ALPHARMA PHARMS

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    8158156
    2027-06-19
    U-1510
    22321
    MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG TERM OPIOD TREATEMENT BY ORALLY ADMINISTERING AN INTACT COMPOSITION AS CLAIM
    3
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY